Colfosceril Palmitate

棕榈胆磷

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameColfosceril Palmitate
Drug Alias Name二棕榈酸磷脂酰胆碱colfoscerili palmitaspalmitato de colfoscerilo1,2-二棕榈酰基卵磷脂二软脂酸磷脂酰胆碱 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsRespiratory Insufficiency
Global Approved IndicationsRespiratory Insufficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1990/08/02
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsRespiratory Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeR07AA01
Related LinksWikipediaDrugBankKEGG